Sylviane Muller
15Patents
3h-index
30Co-inventors
60Inventor score
Filing activity: Feb 26, 1991 → Jul 13, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7741280B2 | Multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments | Emerging Cross-Sectional Technologies | 13 | Active |
| US6455244B1 | Methods for the detection of antibodies associated with autoimmune disorders and infectious agents employing immunoretroid peptides derived from antigens associated with said disorders and agents | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5407833A | Peptides of the SM-D antigen and their use for diagnosis of systemic lupus erythematosus | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5545718A | Synthetic peptides of the conjugate of ubiquitine and H2A histone | Human Necessities | 2 | Expired |
| US7872098B1 | Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies | Human Necessities | 2 | Active |
| US7364744B2 | Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV | Chemistry; Metallurgy | 1 | Expired |
| US8173767B2 | Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV | Chemistry; Metallurgy | 1 | Active |
| US9458212B2 | Nanoparticles containing a peptide, vectors containing said nanoparticles, and pharmaceutical uses of said nanoparticles and vectors | Human Necessities | 0 | Active |
| US8475800B2 | Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies | Human Necessities | 0 | Active |
| US9017673B2 | Peptide analogues comprising at least one type of aminoacylaza-$g(b)<sp>3</sp>and the use thereof, in particular for therapy | Emerging Cross-Sectional Technologies | 0 | Active |
| US8058281B2 | Use of adenine-derived compounds for the treatment of lupus | Human Necessities | 0 | Active |
| US9657072B2 | Modified peptides and their use for treating autoimmune diseases | Human Necessities | 0 | Active |
| US10213482B2 | Methods of treating chronic inflammatory diseases | Chemistry; Metallurgy | 0 | Active |
| US11046657B2 | Pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokines | Chemistry; Metallurgy | 0 | Active |
| US5427958A | Synthetic peptides of the conjugate of ubiquitine and H2A histone | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.